Skip to main navigation Skip to search Skip to main content

Pharmacophore-based discovery of FXR-agonists. Part II: Identification of bioactive triterpenes from Ganoderma lucidum

  • Ulrike Grienke
  • , Judit Mihaly-Bison
  • , Daniela Schuster
  • , Taras Afonyushkin
  • , Markus Binder
  • , Shu-hong Guan
  • , Chun-ru Cheng
  • , Gerhard Wolber
  • , Hermann Stuppner
  • , De-an Guo
  • , Valery N. Bochkov
  • , Judith M. Rollinger

Publications: Contribution to journalArticlePeer Reviewed

Original languageEnglish
Pages (from-to)6779-6791
Number of pages13
JournalBioorganic & Medicinal Chemistry
Volume19
Issue number22
DOIs
Publication statusPublished - 15 Nov 2011
Externally publishedYes

Funding

This work was funded by the National Research Network (NFN)-project 'Drugs from Nature Targeting Inflammation' S10703/S10711/S10713 granted by the Austrian Science Fund (FWF). D. S. is grateful for a young talents grant and the Erika Cremer Habilitations Program from the University of Innsbruck.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 14 - Life Below Water
    SDG 14 Life Below Water

Austrian Fields of Science 2012

  • 104013 Natural product chemistry

Keywords

  • Farnesoid X receptor
  • Ganoderma lucidum
  • Lanostane triterpenes
  • Ganoderic acids
  • Molecular modeling
  • Virtual screening
  • Natural products
  • FARNESOID-X-RECEPTOR
  • BILE-ACID RECEPTOR
  • NATURAL-PRODUCT GUGGULSTERONE
  • ORPHAN NUCLEAR RECEPTOR
  • HYPERLIPIDEMIC RATS
  • GENE-EXPRESSION
  • MARINE SPONGE
  • POTENT
  • LIGAND
  • ACTIVATION

Cite this